<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 125 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page124.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=125">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 125 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 125</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=125"><img src="../thumb/125.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>94 / 2020-04                                                          Cardio-Vascular Agents - 7.2
   Dosage: Admin.only where card.monit.& defibrillat. facilit.exist. Std.  incr. risk of torsade de pointes with drugs which prolong QT interv.  lat. in pts.with disabl.sympts., prem.ventric. contracts.non-sustain.
   dos. 5 mg/kg bm by IV infus.over 20 min.-2 hrs.(admin.pref.as dil.sol.in   or agents induc.hypokalaem., alters. high prot.bound meds.conc.  ventricul.tachycard.caus. disabl. sympts., maint.of norm.rhythm.
   250 ml 5% dextr.) Rep.infus.up to 1200 mg (ie. approx. 15 mg/kg bm)   follow. other convers.
   in up to 500 ml 5% dextrose /24 hrs. Adjust.infus.rate to clin.respons.   INDERAL, AstraZeneca Pharmaceuticals (Pty) Ltd  (S4) TABS, [P/S] S/6.2/17.
   May be given as a 150-300 mg bolus inj.in 10-20 ml over minim.of 3   See Section 7.4.2  813915-007: 100 mg, 60, R687,89
   min.in ICU situat. Should not be repeat. for at least 15 mins. Transf.  LIGNOCAINE HCl FRESENIUS AMPS, Fresenius Kabi [P/S]  Dosage: Supra-ventric.dysrhythm: Init. 50 mg 2xdly, most pts.
   to oral therapy once adeq. respons. est.phas.out grad.  Lignocaine hydrochloride anhydr.  control., however may be incr.to max. 300 mg dly.
                            st
   Cardiopulmon.resus.of shock resist.ventric. fibrillat: 1  dose:   Indications: Ventricul.arrhythm., dur.open-heart surg., ac.MI, aft.  Ventric.dysrhythm: Init. 100 mg 2xdly.with max. of 400 mg dly., pro-
   300 mg dil.in 20 ml 5% dextr.or 5 mg/kg bm dil.in 30 ml 5% dextr.  digoxin OD.  gress.reduc.dos.aft. 3-5 days to low. control.level. Init.treatm.in hosp.
   admin.via bolus IV inj. Addit.150 mg or 2.5 mg/kg IV dos.may be con-  (S4) INJ. M/4/255, V/6.2/319  (S4) INJ, [P/S] S/6.2/16. 10 mg/ml.
   sid.if ventric.fibrillat.persists.  782300-006: 2%amps, 10x5 ml, R44,13  813869-005: 1x5 ml amps, R863,41
   Contra-indications: Sinus bradycard., sino-atrial heartblock, sick si-  702061-001: 10%amps, 10x5 ml, R206,41  Dosage: IV use only.
   nus syndr.,sev.conduct.disturbs. or sinus node dis. (unless in conjunct.  Dosage: Emerg.ac.MI: 300 mg IMI, then 0,1%-0,2% IV infus.at   Bolus inj: In emerg./for rapid effect: Slow IVI of 2 mg/kg over not
   with pacemaker), thyroid dysfunct., I-hypersens.for 200 mg tabs.& inj.,   rate of 1-4 mg/min.accord.to pts. needs.  less than 10 mins.,or in div.dos.
   breastfeed., pregn., sunlight expos., ac. porphyr., concom.sotalol.,   Card.arrhythm: 50-100 mg slow IV inj.over 2 mins.  IV infus: When prolong.parenter.admin.reqd. Init. therapy by slow
   paeds. Inj.also: sev.resp.fail./circulat. collapse/sev.arter. hypotens.,   Contraindications: Hypovolaem., heartblock, other conduct.disturb.,   inj.of 2 mg/kg over 30 mins. then continue with IV infus.at 1,5 mg/
   myocardiopath., CHF when used as bolus inj., combin.therap.with   bradycard., card. decompensat., hypotens.  kg per hour for 1st hr.& at 0,1-0,25 mg/kg/hr.dur.2nd.& later hrs. In-
   agents which may induc.Torsade de Pointes, prophylact.use in preop.   Side effects: CNS excitat.follow.by depress.& simultan.CV syst.de-  fus. should not exceed 24 hrs. Max. cumulat. dos. in 1st 24 hrs.not
   per.of cardiopulm.surg.      press., allerg.reacts., drowsin. lassit., amnes., tong.& perioral.numbn.,   to exceed 600 mg.
   Side-effects: Potent.fatal toxic.esp.pulm.toxic., liv.disords., ar-  foet. intoxicat. (use dur.labour), methaemoglobinaem.  Contraindications: CF, rec./hist.of MI with asymptomat. ventricul.
   rhythm.poss.exacerbat., heartblock/ sin.bradycard., corneal micro-  Special precautions: Hepat.insuff., card. condits., epilep., myasth.  ectopics/asymptomat. nonsustain. ventric.tachycard., pregn.& lac-
   depos. (cont. ther.), bronchosp.,dyspn., opthalm.abnormalit.incl.optic   grav., imp.resp.funct.  tat., long stand.atrial fibrillat., haemodynamic signific. valvul. heart
   neuropathy, bradycard., sinus arrest, conduct. disturbs., poss.photo-  dis., cardiogen.shock & unless pacing rescue avail.in sinus node
   sens.& other skin reacts., erythema dur.course of radio-ther., hyper/   LIGNOCAINE-HCl B BRAUN, B Braun   dysfunct., atrial conduct. defects, 2nd degr./great.AV-block., bundle
   hypothyroid., SIADH, diffuse pulm.alveolit., chron. liv. dis. dur.longt.  Medical.  branch/ distal.block.
   ther., periph.neuropathy &/ myopathy, CNS effs., trem., atax., benign   Lignocaine HCl.  Side effects: V.common: Giddin., dizz., light-headedn., periph.
   rais.IC-press., ECG chang., N&V, metall.taste, fatig., epididymo-orchit.,   Indications: Ventric.arrhythm.follow.card.infarct. / gen anaesthes.,   neuropathy, paraesthes., atax., double/blurr.vis. Common: Pro-dys-
   hypersens.react., impot., vasculit., haemolyt. anaem. Inj.also: Loc.re-  dur.card.cauterisat.& open heart surg.  rhythm.eff. partic.with struct.heart dis/signific.L.ventric. impairm.,
   acts., trans.BP reduct.& circulat.collapse, anaphylact. shock, tempor.  (S4) INJ. 2%, 39/4/0437, 20 mg/ml.  1:1 AV conduct.follow.init.atrial slow. Uncommon: Corn.deposits.
   hot flushes, sweat., naus with rapid IV admin.  709418-001: 20x5 ml amps, R73,39  Rare: N&V, jaund., elev.liv.enzym., photosens. V.rare: pneumonit.,
   Special precautions: Thyroid funct.tests bef. start. & dur.ther.also   Dosage: Ventric.arrhythm: Slow IVI 50-100 mg over 2 mins. Poss.  pulm.fibros., interstit.lung dis.
   for some mnths.aft.discont. treatm. esp.in elderly, too high a dos.may   necess.to rep.dos.aft.20-30 mins. OR Give load.dos.follow.und.ECG   Warnings and special precautions: Correct pre-exist.hypo-/hy-
   lead to sev. bradycard.& conduct.disturbs.with appear.of idioventric.  control by 0,1% or 0,2% infus.of 1-4 mg/min.x12-48 hrs.  perkalaem., use only in hepat. impairm.if potent.benefits outweigh
   rhythm partic.in elderly or dur.digit ther., exist.HF poss.worsen.by   Contraindications: Amide type loc.anaesthet. hypersens., heart   risks with plasma monit.recomm., perman.pacemakers/ tempor.
   ther., latent/ manifest. HF, elderly, dyspn.& non-product. cough on-  block, sev.card.conduct. disturbs., ac.heart fail., hypovolaem.shock,   pacing electrod., diffic.in obtain.ventric. threshholds of less than 1
   set poss.relat.to pulmon.toxic., pts.to be hospitalis. while load.dos.  hypotens. unrelat.to treatable tachyarrhythm., myasthen.grav., safey   volt at init.implantat., predisposit. to card.fail., dffic.exper.in defibril-
   giv., excess.dos.dur. maint. ther. relat.to excess.tiss.retent.of drug &   in pregn.& lactat.not est.  lat. some pts., ac onset of atrial fibrillat.follow.card. surg., post MI
   /its metabolit., monit.pts.reg.for excess.dos.detect. & adjustm., reg.   Side effects: Allerg.contact dermatit., burn., sting., tendern., ure-  pts.with asymptomat.ventric. dysrhythm., elderly, childr.und.18 yrs.,
   opthalm.exam.advis.dur.longt. ther., pro-arrhythm. eff.usually occurs   thrit., CNS stimulat., drowsin., lassit., amnes., CV syst.depress., ar-  contin.ECG monit. when bolus dos.admin., admin.more slow. to pts.
   in combinat. with other precipitat.fact.partic.other antiarrhytyhm.   rhythm., bradycard., card.arrest, anaphylax., methaemoglobinaem.,   in sustain.ventric.tachycard., with card.fail. hist.when decompensat.
   agents/digox.& hypokalaem., withdr. if hyperthyroid.develop., sev.  tong.& perioral regn.numbn.  poss.give init.dos.over 30 mins., plasma lev.monit.with IV infus.& up-
   thyroid hyperactiv./ hypofunct.can be treat.with concom. suit.ther.,   Special precautions: Concom.propanol./ diltiazem/ verapamil &   per edge dos.range.
   utilize.altern.agents first due to poss life-threat.probl., monit.liv.  cimetidine, childr./elderly & debilitat., liv.dis., poss.precipitat.seiz.in   Interactions: Class 1 antiarrhythm./Ca chann. blocks. with an-
   funct., freq.prothromb. monit.with concom. anticoags., potent.sev.   epilept., card.condits., imp.resp.funct.  tiarrhythm.activ.not recomm., plasma digox.lev.rise, poss. addit.
   complicat. in pts.undergo.gen.anaesth., ac.resp. distress.aft CV surg.  Drug interactions: Anti-arrhythm.agents( eg. mexiletine/tocainide)   negat.eff.of ß-block.& other card.depress., incr. eliminat.rate with
   Drug interactions: Eff.of warfarin, other anticoags. & clonazapam   incr.cardiotox.risk, propanol /diltiazem & verapamil reduc.plasma   known enzyme induc., incr. plasma lev.& half-life with cimetidine,
   poss.enhanc., plasma conc. of cyclosporin, digoxin, flecainide, phe-  clear., addit. effs.on cardiovasc.& CNS syst., poss.toxic.lev.with ci-  twofold or more incr.in plasma lev.with amiodarone.
   nytoin, procainemide & quinidine poss.rais., ß-block. & Ca-antagon.  metidine, addit.card.depress.eff.with ß-block./ other anti-arrythm.&   (S4) CR CAPS, [P/S] 37/6.2/0199, 0201
   ther.potent., incr.risk of torsade de pointes with drugs which direct/  IV phenytoin, hypokalaem. produc.by acetazolamide/loop diuret.&   Indications: Sust.ventric.tachydysrhythm., AV nodal reciprocat.
   indirect.prolong QT interv.or agents induc.hypokalaem.incl.anti-dys-  thiazides antagon.effs.  tachycard., Wolff-Parkinson White syndr.& simil.condits.with ac-
   rhythm.agents eg.class 1a anti-arrythm/ sotalol/bepridil/disopyram/  PURBLOKA, Litha Pharma (Pty) Ltd  cess.pathway & antero / retrograde conduct., paroxysm.atrial fibril-
   quinidin., non-antidysrhythm. agents eg. Vincamine/cert. neurolept.   See Section 7.4.2  lat. in pts.with disabl.sympts., prem.ventric. contracts.non-sustain.
   agents/cisapride/erythromyc.IV/ pentamidine, cert.antihistam.eg.   ventricul.tachycard.caus. disabl. sympts., maint.of norm.rhythm.
   astemizol./ mizolastin., anti-malarials eg. quinine/mefloquin./ chlo-  RAVAMIL SR, Merck (Biopharma Division)  follow.other convers.
   roquin./ halofantrin., Li and TADs eg. doxepin/ maprotiline /amitrip-  See Section 7.4.1  717802-001: 100 mg, 30, R343,95
   tyline, and fluoroquinolon., phenytoin decr.plasma conc., cimetidine   REMICAINE, Adcock-Ingram Healthcare (Pty) Ltd  717803-001: 200 mg, 30, R687,89
   & other inhibit.of metabol.enzymes incl.HIV prot.inhibit& grapefr.  Dosage: Admin.as once dly.dos. Dos.may be incr./ decr.in steps of
   juice incr.plasma conc., incr.risk of musc. toxic.with lidocain./tac-  See Section 2.2  50 mg/day. Min.4-5 days necess.to est.new steady state plasma
   rolim./sildenaf./midazol./ triazol./ dihydroergotamin./ergotamin./  RYTHMODAN, Sanofi-Aventis [P/S]  lev.aft. modificat.
   simvastat. & other statins metab.by CYP3A4, incr.fentanyl toxicit.  Disopyramide.  Supraventricul.tachycard: Init.dos: 100 mg/ day consid.incr.
   with concom.use.             Indications: Prem.ventric.& atrial contract., paroxysmal atrial tachy-  only aft.4-5 days. Optim.dos: 200 mg/ day. Max.dos: 300 mg/day.
   Warnings: Cordarone-X IV is incompat.with saline, admin solely in   card., dur.or aft.surg. proced./follow.digital.or similar glycoside use     Ventricul.tachycard: Usual dos: 200 mg/day consid.incr.only aft.4-
   5% Dextr.Sols, sols of less than 2 amps Cordarone-X IV in 500 ml 5%   when complicat.by the arrythm.mention.  5 days. Max.dos: 300 mg/ day.
   Dextr unstable and should not be used., as eliminat.& absorpt.vari-  (S4) CAPS, [P/S] E/6.2/163   High risk pts: Init.dos.not to exceed 100 mg/24 hrs. Range: 50-
   able maint. dos. select.is diffic.requir. poss. dos.decr./discont., sub-  761826-009: 100 mg, 100, R819,30  100 mg/24 hrs.
   stitut.to other antiarrythm. diffic.as amiodarone body burd. changes   Dosage: 300-800 mg/day giv.as 100 mg 6 hrly.& to be adjust.ac-  Change over: Bas.on tot.dly.dos.of Tambocor tabs.
   grad and unpredict.          cord.to respons.              Contraindications: Old or ac.MI, HF regard.of type of dysrhythm.,
                                                                                    rd
                                                                                 nd
   HEXARONE 100, 200, Sandoz [P/S]  Contraindications: Concom.potent.diuret. treatm., CCF, safety in   compl.(L) bundle branch block, bifascicul.block, 2  & 3  degr.AV block,
                                                              sinus node dysfunct.& atrial dis.in absence of pacing, long stand.atrial
                                pregn.not est., lactat., non-pac.2 /3  degree AV block, bundle-branch
                                               rd
                                             nd
   Amiodarone HCl.              block assoc.with 1  degr.AV block, double block, pre-exist. long QT,   fibrillat., haemodynamic signific. valvul.heart dis., gen.not recomm.
                                        st
   Indications: Prevent.of tachyarrhythm.assoc. with WPW-syndr.&   sev.sinus node dysfunct., sev.HF unless second.to card.arrhythm.,   with concom. class 1 dysrhythm.
   other paroxysm. tachyarrhythm. incl.supraventric., nodal & ventric.   concom. antiarrhythm. /drugs.that provoke ventric. arrhythm. & tor-  Side effects: V.common: Giddin., dizz., light-headedn., periph.
   tachycard., atrial flutt.& fibrillat., ventric. fibrillat.when other meds.  sades de pointes, haemodynamic. non-signific. asymptomat.ventric.  neuropathy, paraesthes., atax., double/blurr.vis. Common: Pro-dys-
   cannot be used.              premat.contract., insuffic. data for paed.use.  rhythm.eff. partic.with struct.heart dis/signific.L.ventric. impairm.,
   (S4) TABS, 32/6.2/0650, 0651  Side effects: Worsen./provocat.of ventric. arrhythm esp.in pres.of   1:1 AV conduct.follow.init.atrial slow. Uncommon: Corn.deposits.
   863157-009: 100 mg, 30, R248,87  hypokalaem., intra-card. conduct.abnormal., other arrhythm., sev.HF,   Rare: N&V, jaund., elev.liv.enzym., photosens. V.rare: pneumonit.,
   863165-001: 200 mg, 30, R443,58  collapse, cardiogen.shock, hypotens., ren.insuffic., hepat. ischaem.,   pulm.fibros., interstit.lung dis.
   Dosage: Indiv. Init: 200 mg 3xdly.x1 wk., then 200 mg 2xdly.x1 wk.   dysur., ac.urin.retent., vis. disturbs., GI disturbs., impot., psych.disords.,   Warnings and special precautions: Induc.more sev.dysrhythm.,
   Maint: 200 mg dly.or less if appropr. Review regular.  skin reacts., anaphylact.type reacts., hypoglycaem., cholestat.jaund.,   incr. freq.of pre-exist.dysrhythm., worsen. sympts., elderly, discont.
   Contraindications: Sinus bradycard., sino-atrial heartblock, sev.  headache, dizzin., neutropen.  treatm.in the case of more numerous/ polymorph.ventricul. premat.
   conduct.disturbs.unless in conjunct. with pacemak., thyr.dysfunct.,   Special precautions: Digital.pts.with any degree HF bef.treatm.,   complexes, hist./sympts.of HF, pre-exist. conduct. disords., discont.
   sev.resp. fail., iodine sens., pregn.& lactat., porphyr., concom. sotalol.  excret.in breast milk, struct. heart dis., proarrhythm., card. decom-  if AV block/perman. complete branch block/ sinoatrial block occur
   Side effects: Corneal microdepos., imp.vis. acuity, bradycard./ sinus   pensat., always init.treatm.in hosp.und. strict. clinic.& ECG surveil-  dur. treatm., decr.dos. if QRS complexes widen by more than 25%
   arrest, conduct.disturbs., photosens., revers.blue skin discolourat., hy-  lance, hypokalaem., ren./ hepat.insuffic., narr.angle glauc., prostat.   of baseline values, ECG monit.with dos. modificat./ concom.treatm.
   per./ hypothyroid., sev.pulm.toxic.incl.fibros.& interstit. pneumonit.,   enlargem., myasth.grav.poss.aggrav., monit.bld. sugar lev.of pts.at   affect.card.conduct. esp. with pre-exist.conduct.disords., correct
   diffuse pulm.alveolit., ac./chron.liv. disords., revers.periph.neuropa-  risk of hypoglycaem., inhibit.of CYP3A enzyme not recomm., hy-  pre-exist. hypo-/ hyperkalaem.or hypomagnesaem., ren. insuffic.,
   thy, CNS effs., vertigo, benign rais.IC-press., ECG chang., N&V, metall.  pokalaem.induc. drugs.  safety in pregn.& lactat.not est., insuffic.evid.in childr.und.18 yrs.&
   taste, fatig., epididymo-orchit., hypersens. reacts.  Drug interactions: Signific.inhibit.of hepat. CYP3A enzyme poss.  liv.funct. impairm.
   Special precautions: Excess.sunlight expos., reg.opthalm.exam-  incr.serum lev., atrop.& other anticholinerg.may potent the atrop.-like   Interactions: Incr.adverse card.effs.with Class I anti-dysrhythm., incr.
   in., poss.arrhythm. dur.withdr. period., use minim.effect.dos., latent/  effs., ser. lev.of drugs metabol.by CYP3A enzym.incr.  plasma lev.with cimetidine, close clinic.& ECG monit.part.elderly &
   manifest. heart fail., monit.thyr.funct.reg.dur.& aft.discont., withdr.in   when init. treatm.with concom.meds.with negat.inotrop./ bradycard.
   case of hyperthyroid., eval.pts.with dyspn., monit.liv.funct.dur.& aft.  TAMBOCOR, iNova [P/S] &  propert.and/or slow.AV or intraventric. conduct.
   treatm., elderly, proarrhythm.eff.usuall.occurs in combinat.with other   Flecainide acet.  See also MDR page 396.
   precipitat.fact., gen.anaesth.  Indications: Sust.ventric.tachydysrhythm, AV nodal reciprocat.
   Drug interactions: Digox.& oral anticoags. plasma conc.rais., negat.  tachycard., Wolff-Parkinson White syndr.& simil.condits.with ac-  TENORMIN, AstraZeneca Pharmaceuticals (Pty) Ltd
   chronotrop.& dromatrop. propert.of ß-block.& Ca chan.block.potent.,   cess.pathway & antero / retrograde conduct., paroxysm.atrial fibril-  See Section 7.4.2</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page124.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page120.html">120</a>&nbsp;&nbsp;&nbsp;<a href="page121.html">121</a>&nbsp;&nbsp;&nbsp;<a href="page122.html">122</a>&nbsp;&nbsp;&nbsp;<a href="page123.html">123</a>&nbsp;&nbsp;&nbsp;<a href="page124.html">124</a>&nbsp;&nbsp;&nbsp;<a href="page125.html">125</a>&nbsp;&nbsp;&nbsp;<a href="page126.html">126</a>&nbsp;&nbsp;&nbsp;<a href="page127.html">127</a>&nbsp;&nbsp;&nbsp;<a href="page128.html">128</a>&nbsp;&nbsp;&nbsp;<a href="page129.html">129</a>&nbsp;&nbsp;&nbsp;<a href="page130.html">130</a>
             </td>
             <td width="35%"><a href="page126.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page126.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
